ROSEMONT PHARMACEUTICALS LTD has a total of 33 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2007. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and furniture and games are IYER RAVI RAMAMOORTHY, CHEN MAN and NANJING ZHONGKE GROUP CORP LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 12 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Furniture and games |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Physical training equipment |
# | Name | Total Patents |
---|---|---|
#1 | Tierney Carl | 6 |
#2 | Jones Geraint | 6 |
#3 | Powell Stacey | 6 |
#4 | Mustafa Tajamal | 6 |
#5 | Braybrooke Peter | 6 |
#6 | Hutchinson Paul | 5 |
#7 | Driver Phillip | 4 |
#8 | Soderberg Ingrid | 2 |
#9 | Tiernery Carl David | 1 |
#10 | Phillip Driver | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020104837A1 | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability | |
AU2017312356A1 | Stable atorvastatin suspension composition | |
GB201219884D0 | New composition and preparation thereof | |
GB201200192D0 | Methotrexate composition | |
GB0911820D0 | Candesartan composition | |
GB0908732D0 | Bicalutamide composition | |
GB0906604D0 | Felodipine composition | |
GB0820804D0 | Perinropril composition and method of use thereof | |
GB0814466D0 | Sertraline composition | |
GB0811227D0 | Venlafaxine composition and method of manufacture thereof | |
GB0807068D0 | Rosiglitazone solution | |
GB0804536D0 | Losartan composition | |
GB0804242D0 | Clopidogrel solution | |
AU2007245410A1 | Liquid oral compositions |